|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.25/-0.25
|
企业价值
1.13B
|
资产负债 |
每股账面净值
1.99
|
现金流量 |
现金流量率
--
|
损益表 |
收益
863.50M
|
每股收益
1.24
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/28 07:38 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals. |